141 related articles for article (PubMed ID: 9864247)
21. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
22. Cytokines in leprosy, I. Serum cytokine profile in leprosy.
Moubasher AD; Kamel NA; Zedan H; Raheem DD
Int J Dermatol; 1998 Oct; 37(10):733-40. PubMed ID: 9802682
[TBL] [Abstract][Full Text] [Related]
23. Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.
Costa RD; Mendonça VA; Soriani FM; Lyon S; Penido RA; Costa AM; Costa MD; Terra Fde S; Teixeira MM; Antunes CM; Teixeira AL
Mem Inst Oswaldo Cruz; 2013 Dec; 108(8):1051-6. PubMed ID: 24402158
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
Sarno EN; Grau GE; Vieira LM; Nery JA
Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
[TBL] [Abstract][Full Text] [Related]
25. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
26. Elevation of serum eosinophil cationic protein, soluble tumor necrosis factor receptors and soluble intercellular adhesion molecule-1 levels in acute bronchial asthma.
Kokuludağ A; Sin A; Terzioğlu E; Saydam G; Sebik F
J Investig Allergol Clin Immunol; 2002; 12(3):211-4. PubMed ID: 12530121
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
[TBL] [Abstract][Full Text] [Related]
28. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC; Li L; Hsieh M; Liao S; Chang KS
Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
[TBL] [Abstract][Full Text] [Related]
29. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people.
Hasegawa Y; Sawada M; Ozaki N; Inagaki T; Suzumura A
Gerontology; 2000; 46(4):185-8. PubMed ID: 10859456
[TBL] [Abstract][Full Text] [Related]
30. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects.
Liebmann PM; Reibnegger G; Lehofer M; Moser M; Pürstner P; Mangge H; Schauenstein K
Int Immunol; 1998 Sep; 10(9):1393-6. PubMed ID: 9786439
[TBL] [Abstract][Full Text] [Related]
31. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
Jónasdóttir O; Petersen J; Bendtzen K
APMIS; 2001 Nov; 109(11):781-6. PubMed ID: 11900058
[TBL] [Abstract][Full Text] [Related]
32. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
33. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
34. Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions.
Parida SK; Grau GE; Zaheer SA; Mukherjee R
Clin Immunol Immunopathol; 1992 Apr; 63(1):23-7. PubMed ID: 1591878
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.
Gupta A; Sharma VK; Vohra H; Ganguly NK
Clin Exp Immunol; 1999 Jul; 117(1):56-62. PubMed ID: 10403916
[TBL] [Abstract][Full Text] [Related]
36. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
[TBL] [Abstract][Full Text] [Related]
38. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
[TBL] [Abstract][Full Text] [Related]
39. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.
Edwards CK
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I73-81. PubMed ID: 10577978
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of soluble tumor necrosis factor receptor two in plasma of HIV-seropositive individuals who use opiates.
Ryan LA; Brester M; Bohac D; Morgello S; Zheng J
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):41-5. PubMed ID: 15000697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
